Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariola Cieśla-Dul

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Atherosclerosis|February 18, 2011
Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliteransAnetta Undas, Tomasz Nowakowski, Mariola Cieśla-Dul, et al.
Polskie Archiwum Medycyny Wewnetrznej|August 22, 2009
Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation controlAnetta Undas, Mariola Cieśla-Dul, Marek Zółciński, et al.
Thrombosis Research|July 6, 2012
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoformAnetta Undas, Mariola Cieśla-Dul, Tomasz Drążkiewicz, et al.
Thrombosis Research|June 25, 2013
Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosisMarek Żółciński, Mariola Cieśla-Dul, Daniel P Potaczek, et al.
Przeglad Lekarski|October 25, 2003
[Asymptomatic carotid stenosis: ACS]Mariola Cieśla-Dul, Dorde Radak, Roman Pfitzner, et al.
Polskie Archiwum Medycyny Wewnetrznej|December 17, 2009
Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case reportMariola Cieśla-Dul, Bogusław Gaweda, Ewa Wypasek, et al.
Przeglad Lekarski|February 24, 2005
[Low ejection fraction as risk factor after aortic valve replacement]Mariola Cieśla-Dul, Roman Pfitzner, Rafał Drwiła, et al.
Kardiologia Polska|October 19, 2011
Association between selected risk factors and the incidence of venous obstruction after pacemaker implantation: demographic and clinical factorsJacek Lelakowski, Teresa Barbara Domagała, Mariola Cieśla-Dul, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Atherosclerosis|February 18, 2011
Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliteransAnetta Undas, Tomasz Nowakowski, Mariola Cieśla-Dul, et al.
Polskie Archiwum Medycyny Wewnetrznej|August 22, 2009
Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation controlAnetta Undas, Mariola Cieśla-Dul, Marek Zółciński, et al.
Thrombosis Research|July 6, 2012
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoformAnetta Undas, Mariola Cieśla-Dul, Tomasz Drążkiewicz, et al.
Thrombosis Research|June 25, 2013
Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosisMarek Żółciński, Mariola Cieśla-Dul, Daniel P Potaczek, et al.
Przeglad Lekarski|October 25, 2003
[Asymptomatic carotid stenosis: ACS]Mariola Cieśla-Dul, Dorde Radak, Roman Pfitzner, et al.
Polskie Archiwum Medycyny Wewnetrznej|December 17, 2009
Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case reportMariola Cieśla-Dul, Bogusław Gaweda, Ewa Wypasek, et al.
Przeglad Lekarski|February 24, 2005
[Low ejection fraction as risk factor after aortic valve replacement]Mariola Cieśla-Dul, Roman Pfitzner, Rafał Drwiła, et al.
Kardiologia Polska|October 19, 2011
Association between selected risk factors and the incidence of venous obstruction after pacemaker implantation: demographic and clinical factorsJacek Lelakowski, Teresa Barbara Domagała, Mariola Cieśla-Dul, et al.
Pageof 1